Please login to the form below
1
Revenue 2017Pfizer
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.
Pfizer’s Abrysvo RSV vaccine recommended by US CDC for infants
Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation of pregnant women, has been backed by the US Centers for Disease Control ... Pfizer’s Abrysvo is set to become the first
Pfizer’s Litfulo approved by EC for adults and adolescents with severe alopecia areata
The autoimmune disease affects approximately 147 million people globally. Pfizer’s Litfulo (ritlecitinib) has been approved by the European Commission (EC) to treat adults and adolescents with severe alopecia areata. ... Angela Hwang, chief commercial
Date set for EU antitrust regulators to decide on Pfizer’s $43bn Seagen acquisition
EU antitrust regulators will make a decision on Pfizer’s proposed $43bn acquisition of Seagen by 19 October, according to a recent regulatory filing. ... The deal would also grant Pfizer access to Seagen’s drug development pipeline as well as its
Moderna’s XBB.1.5-adapted COVID-19 vaccine receives MHRA approval
The approval comes shortly after Pfizer/BioNTech’s XBB.1.5-adapted COVID-19 vaccine received approval from the UK regulator, also for use in those aged six months and older. ... Pfizer/BioNTech’s updated vaccine is also approved in the EU, and
US CDC recommends updated COVID-19 vaccines for autumn/winter season
Pfizer/BioNTech and Moderna’s updated vaccines will be available in the coming days. ... The recommendation comes after the US Food and Drug Administration (FDA) approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna, which will be
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
